Michel Demaré

Chairman

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 1 buy · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (7 ops.)

€1.0M

▼ Sales (0 ops.)

—

Latest filing published 15 Sept 2026 for AstraZeneca PLC, €354k.

Filing timeline

BuySale

Michel Demaré

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Michel Demaré: trading record in brief

This profile gathers the share dealings of Michel Demaré in AstraZeneca PLC. Over a trading history stretching from 17 February 2020 to 14 September 2026, the count stands at 7 filings.

On the market, this insider has only ever bought: 7 purchases, €1.0M in total. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €116k. Clusters matter here: 1 out of 7 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 15 September 2026 with an open-market purchase (€354k) in AstraZeneca PLC. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Michel Demaré

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

AstraZeneca PLC (SE)AstraZeneca PLC (SE)

Declarations5 total

▲
Michel Demaré
Non-Executive Chair of the BoardExecutives14 Sept 2026AstraZeneca PLC
303,033 GBP0FCA-NSM
2,500 shares@ £121.2133LONISIN GB0009895292FCA-NSM:613d5e67-2529-4055-9fa4-be511083ff7d
Canonical exit: 13 Dec 2026 (T+90)
▲
Michel Demaré
Non-Executive Chair of the BoardExecutives15 Nov 2024AstraZeneca PLC
0RNS
0LONISIN GB0009895292RNS:5432173
Canonical exit: 13 Feb 2025 (T+90)
▲
Michel Demaré
Non-Executive Chair of the BoardExecutives13 Sept 2024AstraZeneca PLC
235,855 GBP12RNS
2,000 shares@ £117.927554.6% of flowLONISIN GB0009895292RNS:5349206
Canonical exit: 12 Dec 2024 (T+90)
▲
Michel Demaré
Non-Executive Chair of the BoardExecutives22 Nov 2023AstraZeneca PLC
101,700 GBP12RNS
1,000 shares@ £101.7050.3% of flowLONISIN GB0009895292RNS:4980407-1
Canonical exit: 20 Feb 2024 (T+90)
▲
Michel Demaré
Non-Executive Chair of the BoardExecutives21 Nov 2023AstraZeneca PLC
101,052 GBP12RNS
1,000 shares@ £101.052249.7% of flowLONISIN GB0009895292RNS:4980407-0
Canonical exit: 19 Feb 2024 (T+90)

5 of 5 declarations

Michel Demaré

Insider track record

Michel Demaré: trading record in brief

Companies and markets linked to Michel Demaré

Similar companies

Related executives